Safety and Efficacy of Glutathione for Skin Lightening

Critical Safety Concerns

Patients with pre-existing liver dysfunction should not receive glutathione due to the risk of idiosyncratic hepatotoxicity and lack of safety monitoring data, as documented by the British Journal of Dermatology 1
Glutathione interferes with liver metabolism, causing both enzyme inhibition and induction, leading to multiple drug interactions, according to the British Journal of Dermatology 1
Case reports document hepatitis following glutathione administration, with two of four cases occurring in patients with methotrexate-induced liver damage, as reported by the British Journal of Dermatology 1

The British Journal of Dermatology recommends that patients with known or suspected liver dysfunction should avoid glutathione entirely given the documented cases of hepatitis and the lack of safety data in this population 1

The British Journal of Dermatology guidelines do not support glutathione use for cosmetic purposes, highlighting the lack of high-quality guidelines addressing glutathione for skin lightening 2, 3
Clinical Nutrition guidelines also do not provide support for glutathione use in skin lightening, underscoring the limited evidence base 4

Patients must be counseled about increased photoprotection needs due to the potential switch from brown eumelanin to red phaeomelanin production, which may increase sun-induced skin cancer risk in previously protected individuals with darker skin tones 2, 4

Long-term cancer surveillance data are completely absent, representing a significant concern for chronic glutathione use 4